At the 62nd Annual Meeting of the European Association for the Study of Diabetes in Milan, Sinocare is demonstrating its latest integrated diagnostic ecosystem. The portfolio spans home, pharmacy, and hospital environments, aiming to bridge the gap between initial risk screening and long-term clinical patient monitoring.
For home users, the company highlighted the Safe AQ max II, a blood glucose system capable of five-second results with Bluetooth connectivity. The exhibit also featured the KUG-11, a three-in-one metabolic meter designed to track glucose, uric acid, and ketones, alongside the GV-100, which extends diabetes care capabilities to pets.
In pharmacy settings, Sinocare is promoting the iCARE-1300 Portable Automatic Multifunction Analyzer. This device processes nearly 100 parameters, including renal function and lipid profiles, within 15 minutes. This technology, paired with their Health Station model, allows pharmacies to transition into active chronic disease screening hubs.
Clinical solutions include the AGEscan, which utilizes fluorescence detection to identify advanced glycation end products without invasive blood sampling. For inpatient care, the Safe AQ 8000 system integrates bedside glucose and CGM data directly into hospital information systems via a dedicated web portal. Founded in 2002, the firm currently serves 25 million users globally, maintaining a significant manufacturing footprint with nine international R&D and production sites.
Comments (0)
No comments yet. Be the first!